SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Steve Research who wrote (5264)8/18/1998 10:59:00 PM
From: Bill Wexler  Respond to of 7041
 
Only two posts...and you have left no doubt that you are a complete idiot.

Congratulations.



To: Steve Research who wrote (5264)8/18/1998 11:01:00 PM
From: drsvelte  Respond to of 7041
 
Steve Research:

I see you have been a member of SI all of one day now! Wow! Many thanks for your reasoned insight. Perhaps you can enlighten all us foolish shorts with a cogent analysis instead of gibberish. By the way, do you live in Mexico?



To: Steve Research who wrote (5264)8/18/1998 11:37:00 PM
From: Bradpalm1  Respond to of 7041
 
Another Zonagen plant joins the thread...sounds like they're starting to get restless at headquarters.

Bradpalm1



To: Steve Research who wrote (5264)8/19/1998 12:15:00 AM
From: Peter V  Respond to of 7041
 
If you tried it and it works, are we to assume that you have a physician-diagnosed erectile dysfunction?



To: Steve Research who wrote (5264)8/19/1998 9:17:00 AM
From: Linda Kaplan  Read Replies (3) | Respond to of 7041
 
Aha. A new member, (no pun intended). What's your real name, please?

Linda



To: Steve Research who wrote (5264)8/19/1998 4:33:00 PM
From: Tokyo VD  Read Replies (2) | Respond to of 7041
 
Steve,

You claim that we can all agree that IF the drug works, THEN chances are the stock is going into the triple digits.

Who says we all agree? Let's say Vasomax receives FDA approval, then it must compete against a more effective product, Viagra. Viagra is the standard of care. Most patients will not switch just because SGP carves a marketing campaign that resembles allergy meds.

Tokyo